202 related articles for article (PubMed ID: 25622902)
1. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice.
Cai KQ; Wang Y; Smith ER; Smedberg JL; Yang DH; Yang WL; Xu XX
Neoplasia; 2015 Jan; 17(1):89-100. PubMed ID: 25622902
[TBL] [Abstract][Full Text] [Related]
2. White spotting variant mouse as an experimental model for ovarian aging and menopausal biology.
Smith ER; Yeasky T; Wei JQ; Miki RA; Cai KQ; Smedberg JL; Yang WL; Xu XX
Menopause; 2012 May; 19(5):588-96. PubMed ID: 22228319
[TBL] [Abstract][Full Text] [Related]
3. Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.
Wang Y; Cai KQ; Smith ER; Yeasky TM; Moore R; Ganjei-Azar P; Klein-Szanto AJ; Godwin AK; Hamilton TC; Xu XX
Mol Cell Biol; 2016 Sep; 36(18):2418-30. PubMed ID: 27354067
[TBL] [Abstract][Full Text] [Related]
4. Oocyte growth and follicular development in KIT-deficient Fas-knockout mice.
Moniruzzaman M; Sakamaki K; Akazawa Y; Miyano T
Reproduction; 2007 Jan; 133(1):117-25. PubMed ID: 17244738
[TBL] [Abstract][Full Text] [Related]
5. Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.
Mullany LK; Fan HY; Liu Z; White LD; Marshall A; Gunaratne P; Anderson ML; Creighton CJ; Xin L; Deavers M; Wong KK; Richards JS
Oncogene; 2011 Aug; 30(32):3522-36. PubMed ID: 21423204
[TBL] [Abstract][Full Text] [Related]
6. Development of a mouse model of menopausal ovarian cancer.
Smith ER; Wang Y; Xu XX
Front Oncol; 2014; 4():36. PubMed ID: 24616881
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis.
Shi M; Whorton AE; Sekulovski N; Paquet M; MacLean JA; Song Y; Van Dyke T; Hayashi K
Biol Reprod; 2020 Apr; 102(5):1055-1064. PubMed ID: 31930396
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.
Burns KH; Agno JE; Sicinski P; Matzuk MM
Mol Endocrinol; 2003 Oct; 17(10):2053-69. PubMed ID: 12855747
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of Trp53 rescues the male fertility defects of Kit(W-v) mice but has no effect on the survival of melanocytes and mast cells.
Jordan SA; Speed RM; Bernex F; Jackson IJ
Dev Biol; 1999 Nov; 215(1):78-90. PubMed ID: 10525351
[TBL] [Abstract][Full Text] [Related]
10. A reduction of cyclooxygenase 2 gene dosage counters the ovarian morphological aging and tumor phenotype in Wv mice.
Yang WL; Cai KQ; Smedberg JL; Smith ER; Klein-Szanto A; Hamilton TC; Xu XX
Am J Pathol; 2007 Apr; 170(4):1325-36. PubMed ID: 17392171
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary.
Elvin JA; Yan C; Wang P; Nishimori K; Matzuk MM
Mol Endocrinol; 1999 Jun; 13(6):1018-34. PubMed ID: 10379899
[TBL] [Abstract][Full Text] [Related]
12. Proliferation and differentiation of spermatogonial stem cells in the w/wv mutant mouse testis.
Ohta H; Tohda A; Nishimune Y
Biol Reprod; 2003 Dec; 69(6):1815-21. PubMed ID: 12890724
[TBL] [Abstract][Full Text] [Related]
13. Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice.
Wu X; Chen L; Brown CA; Yan C; Matzuk MM
Mol Endocrinol; 2004 Jun; 18(6):1509-19. PubMed ID: 15016837
[TBL] [Abstract][Full Text] [Related]
14. Inhibin and p27 interact to regulate gonadal tumorigenesis.
Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
[TBL] [Abstract][Full Text] [Related]
15. Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival.
Mullany LK; Liu Z; King ER; Wong KK; Richards JS
Endocrinology; 2012 Apr; 153(4):1638-48. PubMed ID: 22396451
[TBL] [Abstract][Full Text] [Related]
16. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC; Matzuk MM
Mol Endocrinol; 1999 Jun; 13(6):851-65. PubMed ID: 10379885
[TBL] [Abstract][Full Text] [Related]
17. Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancer.
Wu R; Baker SJ; Hu TC; Norman KM; Fearon ER; Cho KR
Am J Pathol; 2013 Apr; 182(4):1391-9. PubMed ID: 23499052
[TBL] [Abstract][Full Text] [Related]
18. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
19. Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts.
Chen CM; Chang JL; Behringer RR
Oncogene; 2004 Oct; 23(46):7722-5. PubMed ID: 15334065
[TBL] [Abstract][Full Text] [Related]
20. Inhibin subunit gene expression and distribution in the ovaries of immature, young adult, middle-aged, and old female rats.
Jih MH; Lu JK; Wan YJ; Wu TC
Endocrinology; 1993 Jan; 132(1):319-26. PubMed ID: 8419130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
